Display search results for ** instead (30 products)
04 Jul 2016  |  North America
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
USD 6,000.00 save 25 %
16 Aug 2016  |  North America
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...
USD 5,250.00 save 25 %
25 May 2016  |  North America
Combination Therapies and Advanced Manufacturing Techniques are the New Criteria Shaping the $4 Billion Market
Research Overview This Frost & Sullivan research service analyses the current trends, forecasts and the external factors influencing the global cell therapy market. It also studies top participants in the market, disruptive pipeline products, and the opportunities in combination therapy. In addition, it provides a detailed commercialization analys...
03 May 2016  |  North America
Services for the 21st Century House Call
This Frost & Sullivan research service presents a comprehensive analysis of the market potential and dynamics of telehealth virtual visits in the United States. It describes emerging technologies in the telehealth services market and analyses the factors driving the need to deploy virtual or video telehealth solutions across a variety of settings. ...
08 Nov 2016  |  North America
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
16 Nov 2016  |  North America
Better Technology at Lower Costs Pave Way for Market Recovery
This research service presents a global analysis of the cardiac monitoring products market. Market participants were interviewed to obtain their perceptions of cardiac monitoring products and trends. As a result, this study provides an in-depth analysis of the current trends, market size, revenue forecast, and drivers and restraints. It also assess...
30 Nov 2016  |  North America
Third Party Sterilization Services for Care Providers in the US and Western Europe, Forecast to 2022
Hospitals are Increasingly Outsourcing their Surgical Instrument Sterilization - Next Frontier for Disinfection and Sterilization Equipment OEM?
The study covers current and future market trends, drivers, and challenges in outsourcing of hospital sterile processing departments (SPD)/central sterile supply departments (CSSD) to specialized third party vendors. Despite being in the nascent phase, the third party sterilization services market generated total revenue of $1.4 billion in 2015 and...
04 Nov 2016  |  North America
Projecting Market Transformations and Growth Opportunities
Global healthcare trends of aging populations, rising chronic disease prevalence, and urbanization are bound to further strain healthcare systems already grappling with issues of healthcare access, quality, and cost. New treatment paradigms are required that integrate elements of prediction, prevention, and automation to make care more affordable a...
09 Nov 2016  |  North America
As a Third Generation of Technology Emerges, Where is the Market Headed?
This research traces the history of the first clinical applications for robotic devices and all associated technology required to create a true robotic-assisted surgical device (RASD). The study examines the people (leaders) and entities that became pioneers and founders of the RASD industry vertical. With fundamental original equipment manufacture...
11 Nov 2016  |  North America
A Holistic Approach to Preterm Health and Wellbeing
The neonatal devices market will continue to be shaped by the regional and local trends in the annual live births and infrastructure market. The industry is undergoing changes in regards to regulatory protocols, preventive care, reimbursement models, healthcare digitization, patient interests, physician preferences, and executive priorities. Stakeh...